Wegovy, which also contains Semaglutide GLP-1 but at a higher dosage than Ozempic, is specifically approved for obesity treatment and chronic weight management
It is the world's first sustained-release GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes that activates both the GLP-1 and GIP receptors
This effect has led to companies creating GLP-1 medication specifically for weight management, including the FDA-approved drugs Wegovy and Zepbound
Eur J Endocrinol 176:685693 [DOI] [PMC free article] [PubMed] [Google Scholar] 39.Khalid SI, Omotosho PA, Spagnoli A, Torquati A (2020) Association of Bariatric Surgery With Risk of Fracture in Patients With Severe Obesity
Nutrients That Naturally Increase or Support GLP-1 Some nutrients and botanicals can help promote normal GLP-1 activity or work in conjunction with GLP-1 medications
This helps lower blood glucose levels and aids in weight management